Commit To Buy CytomX Therapeutics At $12.50, Earn 17.9% Annualized Using Options
June 15, 2017 at 12:05 PM EDT
Investors considering a purchase of CytomX Therapeutics Inc (CTMX) shares, but tentative about paying the going market price of $13.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $12.50 strike, which has a bid at the time of this writing of 95 cents..